Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 71 record(s)

Req # A-2021-10707

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Muscular Dystrophy Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 11, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
October 2021

Req # A-2021-10708

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Myeloma Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 11, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
October 2021

Req # A-2021-10709

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Mylan Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 11, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
October 2021

Req # A-2021-10777

Copies of all communications between the PMPRB and the clerk of the Health Committee Jean-François Pagé from May 22, 2021 to June 11, 2021. Include internal emails between the PMPRB executives, particularly Tanya Potashnik, Douglas Clark, Mitchell Levine, and Isabel Jaen Raasch, regarding the communications from the clerk and the request to testify.

Organization: Patented Medicine Prices Review Board Canada

3 page(s)
October 2021

Req # A-2021-19384

The daily calendar of meetings, calls and other taskings for Tanya Potashnik from May 1, 2021 to October 14, 2021.

Organization: Patented Medicine Prices Review Board Canada

24 page(s)
October 2021

Req # A-2020-00154

A copy of all materials delivered by developers Windmill Development, Dream Unlimited, Theia Partners and any other names, regarding the development of the Ottawa River islands originally known as “the isles,” but now known as “Zibi,” for the period from 2013 to December 15, 2020.

Organization: National Capital Commission

1464 page(s)
May 2021

Req # A-2021-00043

The most recent report of the Payment in Lieu of Taxes Dispute Advisory Panel regarding the contributions that the NCC makes to the Municipality of Chelsea, as well as the brief to the Dispute Advisory Panel, the most recent media lines and documents expressing support for the NCC’s position.

Organization: National Capital Commission

23 page(s)
May 2021

Req # A-2021-07238

Copies of all information, data, document, or correspondence concerning the PMPRB's classification of the following drug products: NOVORAPID and FIASP, each a product of NOVO NORDISK CANADA INC, a corporation located at 101-2476 Argentia Road, Mississauga, Ontario, Canada L5N 6M1, including but not limited to classifications based on drug product line extensions, similar chemical entities, comparable dosages, or a reasonable relationship between the two drugs, as well as any other analysis, comments, or information related to the classification of these two drugs.

Organization: Patented Medicine Prices Review Board Canada

12 page(s)
May 2021

Req # A-2021-07885

Copies of all briefing notes provided to the Deputy Minister regarding the implementation of the new PMPRB guidelines on July 1, 2021 from January 1, 2021 to April 28, 2021.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
May 2021

Req # A-2021-07888

Copies of all briefing notes provided to the Deputy Minister regarding the possible delay in the implementation of the new PMPRB guidelines from January 1, 2021 to April 28, 2021.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
May 2021
Date modified: